Treatment of follicular non-Hodgkin's lymphoma: The old and the new

被引:25
|
作者
Friedberg, Jonathan W. [1 ]
机构
[1] Univ Rochester, Rochester, NY 14612 USA
关键词
D O I
10.1053/j.seminhematol.2008.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite remaining an incurable disease, overall survival improvements have been noted in patients with advanced-stage follicular lymphoma. The Follicular Lymphoma International Prognostic Index (FLIPI) is a robust prognostic index in this disease, and continues to provide prognostic information in the rituximab era. Rituximab has significantly changed the management of follicular lymphoma, and the most dramatic impact of rituximab is observed in combination with cytotoxic chemotherapy. However, resistance to rituximab remains a problem, and standard therapy in the rituximab-refractory setting includes radioimmunotherapy, autologous stem cell transplantation, and allogeneic stem cell transplantation. In addition, several novel agents show encouraging activity in follicular lymphoma, including bendamustine, lenalidomide, bortezomib, and other proteasome inhibitors, and BCL2 inhibitors. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:S2 / S6
页数:5
相关论文
共 50 条
  • [1] Aggressive treatment in follicular non-Hodgkin's lymphoma
    Schouten, HC
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1996, 56 (10) : 525 - 528
  • [2] Current treatment of follicular non-Hodgkin's lymphoma
    Reiser, M
    Diehl, V
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (09) : 1167 - 1172
  • [3] Follicular non-Hodgkin's lymphoma
    Hayashi, D.
    Lee, J. C.
    Devenney-Cakir, B.
    Zaim, S.
    Ounadjela, S.
    Solal-Celigny, P.
    Juweid, M.
    Guermazi, A.
    CLINICAL RADIOLOGY, 2010, 65 (05) : 408 - 420
  • [4] Preface on follicular non-Hodgkin's lymphoma
    Hagenbeek, Anton
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (02) : 93 - 93
  • [5] Radioimmunotherapy, a new breakthrough in the treatment of follicular non-Hodgkin's lymphoma: The European perspective
    Chatal, JF
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (01) : 1 - 4
  • [6] SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
    M. Provencio Pulla
    J. Alfaro Lizaso
    L. de la Cruz Merino
    J. Gumá i Padró
    C. Quero Blanco
    J. Gómez Codina
    M. Llanos Muñoz
    N. Martinez Banaclocha
    D. Rodriguez Abreu
    A. Rueda Domínguez
    Clinical and Translational Oncology, 2015, 17 : 1014 - 1019
  • [7] SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
    Delvys Rodríguez-Abreu
    Marta Llanos Muñoz
    Mariano Provencio Pulla
    Antonio Rueda Domínguez
    Dolores Isla Casado
    Clinical and Translational Oncology, 2010, 12 : 760 - 764
  • [8] SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
    Provencio Pulla, M.
    Alfaro Lizaso, J.
    de la Cruz-Merino, Luis
    Guma i Padro, J.
    Quero Blanco, C.
    Gomez Codina, J.
    Llanos Munoz, M.
    Martinez Banaclocha, N.
    Rodriguez Abreu, D.
    Rueda Dominguez, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 1014 - 1019
  • [9] SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
    Rodriguez-Abreu, Delvys
    Llanos Munoz, Marta
    Provencio Pulla, Mariano
    Rueda Dominguez, Antonio
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11): : 760 - 764
  • [10] Non-Hodgkin's lymphoma in the elderly - Part 1: Overview and treatment of follicular lymphoma
    Morrison, Vicki A.
    ONCOLOGY-NEW YORK, 2007, 21 (09): : 1104 - 1110